Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Natalizumap can induce progressive multifocal leucoencephalopathy.]
Recent imaging advances in neurology.
Fingolimod (Gilenya) may improve the chances of conception in women with multiple sclerosis (MS) associated with secondary infertlity.
Role of a novel HLA-DQA1*01:02;DRB1*15:01 mixed-isotype heterodimer in the pathogenesis of 'humanized' multiple sclerosis-like disease.
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia.
Insulator Protein Helps Organize the Gaps in the Axon's Insulation.
Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic.
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis.
Influence of Personality on the Relationship Between Gray Matter Volume and Neuropsychiatric Symptoms in Multiple Sclerosis.
The Immune Pathogenesis of Multiple Sclerosis.
Metabolomic approach to human brain spectroscopy identifies associations between clinical features and the frontal lobe metabolome in multiple sclerosis.
Neuroprotection and repair in multiple sclerosis.
Mapping the 12-item multiple sclerosis walking scale to the EuroQol 5-dimension index measure in North American multiple sclerosis patients.
Modulators of the Sphingosine 1-phosphate receptor 1.
Functions of NOD-Like Receptors in Human Diseases.
[Resources and Self-Management Skills in Multiple Sclerosis Patients - Can the Scale Structure of the Questionnaire FERUS be Replicated?]
Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches.
Disability in multiple sclerosis: When synaptic long-term potentiation fails.
ADC evaluation of the corticospinal tract in multiple sclerosis.
Microglia as a critical player in both developmental and late-life CNS pathologies.
Neuroinflammation. Contemporary anti-inflammatory treatment approaches.
Mobility, Walking And Physical Activity In Persons With Multiple Sclerosis.
Substance Name: Simvastatin
Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis.
Pages
« first
‹ previous
…
404
405
406
407
408
409
410
411
412
…
next ›
last »